Clinical Trial Update: Neoadjuvant Chemotherapy Response Assessment by Combined PET-MRI in Borderline and Locally Advanced Pancreatic Adenocarcinoma. [NA]

View source ↗

Summary

This clinical trial update describes a study evaluating the use of combined PET-MRI to assess response to neoadjuvant chemotherapy in borderline and locally adv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Pancreatic Adenocarcinoma | NA | Status: UNKNOWN